HK StockDetailed Quotes

Provided by Tiger Trade Technology Pte. Ltd.

CUTIA-B

5.000

-0.110-2.15%

Volume:86.00K

Turnover:433.13K

Market Cap:1.82B

PE:-3.54

High:5.100

Open:5.100

Low:4.800

Close:5.110

52wk High:12.840

52wk Low:3.640

Shares:363.00M

HK Float Shares:363.00M

Volume Ratio:0.17

T/O Rate:0.02%

Dividend:- -

Dividend Rate:- -

EPS(LYR):-1.412

ROE:-48.56%

ROA:-21.52%

PB:2.12

PE(LYR):-3.54

PS:6.39

Loading ...

Overview Company News Filings

CUTIA-B (02487) Sets 24 Mar 2026 Board Meeting to Approve FY2025 Results and Consider Final Dividend

Bulletin Express

Cutia Therapeutics board to review annual results and consider final dividend

CUTIA-B (Stock Code: 02487) Announces February 2026 Monthly Return

Bulletin Express

Cutia Therapeutics (02487) Announces January 2026 Monthly Return on Movements in Securities

Bulletin Express

CUTIA-B (02487) Shareholder Transfers HK$122 Million Worth of Shares from Citibank to Morgan Stanley Hong Kong Securities

After 10 Months of Delisting from Stock Connect, Liquidity Issues Emerge: Can R&D Breakthroughs Drive CUTIA-B (02487) to Halt Its Decline?

Cutia Therapeutics Reports Positive Phase III Results for CU-20101 Botulinum Toxin Injection in China

Cutia Therapeutics' (HKG:2487) market cap surged HK$258m last week, private equity firms who have a lot riding on the company were rewarded

Simply Wall St.

Cutia Therapeutics Files Director List with HKEX

CUTIA-B (02487): Lu Minfang Appointed as Non-Executive Director

Cutia Therapeutics Appoints Lu Minfang as Non-Executive Director

Cutia Therapeutics (02487) Announces Monthly Return for November 2025, Issued Shares Increase to 364,730,877

Bulletin Express

CUTIA-B (02487): CU-40105 (Self-Developed Topical Finasteride Spray) ANDA Accepted by China's NMPA

Cutia Therapeutics' Topical Finasteride Spray ANDA Accepted by China NMPA

Cutia Therapeutics - Abbreviated New Drug Application for Cu-40105 Self-Developed Topical Finasteride Spray Accepted by Nmpa China

THOMSON REUTERS

CUTIA-B (02487) Sees Stock Price Halved in Two Months: When Will New Product Commercialization Drive a Rebound?

When Will Cutia Therapeutics (HKG:2487) Become Profitable?

Simply Wall St.

HK Stock Movement | CUTIA-B (02487) Surges Over 10% as Topical Minocycline Foam and Finasteride Spray Begin Domestic Sales

Cutia Therapeutics' Acne Drug Data Selected for Oral Presentation at CDA Annual Meeting

MT Newswires Live

CUTIA-B (02487): Post-Hoc Analysis of CU-10201 (Topical 4% Minocycline Foam) Phase III Clinical Trial in China Selected for Oral Presentation at 20th CDA Annual Conference

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www-web.itiger.com/stock/02487/news"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"02487","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"02487\",,,,,undefined,":{"symbol":"02487","market":"HK","secType":"STK","nameCN":"CUTIA-B","latestPrice":5,"timestamp":1773389299069,"preClose":5.11,"halted":0,"volume":86000,"delay":0,"changeRate":-0.02152641878669282,"floatShares":363000000,"shares":363000000,"eps":-1.412177,"marketStatus":"Market Closed","change":-0.11,"latestTime":"03-13 16:08:19","open":5.1,"high":5.1,"low":4.8,"amount":433130,"amplitude":0.058708,"askPrice":5.11,"askSize":1400,"bidPrice":5,"bidSize":400,"shortable":0,"etf":0,"ttmEps":-1.425,"tradingStatus":0,"nextMarketStatus":{"tag":"Open","tradingStatus":2,"beginTime":1773624600000},"marketStatusCode":7,"adr":0,"listingDate":1686499200000,"exchange":"SEHK","adjPreClose":5.11,"openAndCloseTimeList":[[1773365400000,1773374400000],[1773378000000,1773388800000]],"volumeRatio":0.165016501678662,"lotSize":200,"spreadScale":0,"tradeCurrency":"HKD"},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"02487\",,,,,undefined,":{"symbol":"02487","floatShares":363000000,"roa":"-21.52%","roe":"-48.56%","lyrEps":-1.412177,"volumeRatio":0.165016501678662,"shares":363000000,"dividePrice":0,"high":5.1,"amplitude":0.058708,"preClose":5.11,"low":4.8,"week52Low":3.64,"pbRate":"2.12","psRate":"6.39","week52High":12.84,"institutionHeld":0,"latestPrice":5,"committee":-0.555556,"eps":-1.412177,"divideRate":0,"volume":86000,"delay":0,"ttmEps":-1.425,"open":5.1,"prevYearClose":4.54,"prevWeekClose":4.7,"prevMonthClose":4.62,"prevQuarterClose":4.54,"fiveDayClose":4.7,"twentyDayClose":5.12,"sixtyDayClose":6.03},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/02487\",params:#limit:5,,,undefined,":[{"date":"2025-08-28","symbol":"02487","type":"earning","reportTimeType":"","market":"HK","fiscalQuarterEnding":null,"expectedEps":null,"defaultRemindTime":1756344600000,"name":null,"time":"","dateTimestamp":1756310400000,"actualEps":null},{"date":"2025-03-24","symbol":"02487","type":"earning","reportTimeType":"post","market":"HK","fiscalQuarterEnding":null,"expectedEps":null,"defaultRemindTime":1742779800000,"name":null,"time":"Post Market","dateTimestamp":1742745600000,"actualEps":null},{"market":"HK","date":"2024-08-29","symbol":"02487","fiscalQuarterEnding":null,"expectedEps":null,"name":null,"time":"Post Market","type":"earning","dateTimestamp":1724860800000,"reportTimeType":"post","actualEps":null},{"date":"2024-03-27","symbol":"02487","type":"earning","reportTimeType":"","market":"HK","fiscalQuarterEnding":null,"expectedEps":null,"defaultRemindTime":1711503000000,"name":null,"time":"","dateTimestamp":1711468800000,"actualEps":null},{"date":"2023-08-29","symbol":"02487","type":"earning","reportTimeType":"","market":"HK","fiscalQuarterEnding":null,"expectedEps":null,"defaultRemindTime":1693272600000,"name":null,"time":"","dateTimestamp":1693238400000,"actualEps":null}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"02487\",market:\"HK\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"02487\",market:\"HK\",delay:false,,,undefined,":{"strongBuy":0.3333,"buy":0.6667,"hold":0,"sell":0,"strongSell":0,"meanLabel":"BUY","meanPercent":0.6667,"analysts":3,"updateTime":1744041600000},"@#url:\"https://hq.skytigris.cn/hkstock/value_analysis/stock/02487\",params:#withQuantilePoint:true,period:\"5year\",factor:\"peRate\",delay:false,algorithm:1,,,undefined,":{"brief":{"id":"02487","date":"2026-03-12","current":-3.508772,"percent":0.50295,"low":-15.485925,"twenty":-6.425452,"median":-3.469208,"eighty":-1.151513,"high":-0.826569,"avg":-4.242929,"sd":2.965913,"marketCap":1856811895},"quantilePoints":[{"date":"2023-06-16","current":-15.411162,"twenty":-14.413676,"median":-12.389874,"eighty":-12.075055,"marketCap":9394355968},{"date":"2023-06-23","current":-12.436662,"twenty":-14.898766,"median":-13.544522,"eighty":-12.376412,"marketCap":7539806732},{"date":"2023-06-30","current":-12.398371,"twenty":-14.32145,"median":-12.394122,"eighty":-11.447458,"marketCap":7448599392},{"date":"2023-07-07","current":-11.154992,"twenty":-13.792435,"median":-12.336647,"eighty":-11.411148,"marketCap":6688538230},{"date":"2023-07-14","current":-10.800615,"twenty":-12.879806,"median":-11.67313,"eighty":-11.073156,"marketCap":6566928444},{"date":"2023-07-21","current":-9.796084,"twenty":-12.413687,"median":-11.417592,"eighty":-10.790615,"marketCap":5928477067},{"date":"2023-07-28","current":-10.460353,"twenty":-12.393273,"median":-11.232297,"eighty":-10.42688,"marketCap":6323708872},{"date":"2023-08-04","current":-10.844647,"twenty":-12.36968,"median":-11.144468,"eighty":-10.471016,"marketCap":6566928444},{"date":"2023-08-11","current":-11.613111,"twenty":-12.376412,"median":-11.154992,"eighty":-10.495819,"marketCap":6992562695},{"date":"2023-08-18","current":-11.061159,"twenty":-12.34839,"median":-11.14973,"eighty":-10.533878,"marketCap":6612532113},{"date":"2023-08-25","current":-12.606042,"twenty":-12.421346,"median":-11.281516,"eighty":-10.611978,"marketCap":7539806732},{"date":"2023-09-01","current":-3.762061,"twenty":-12.421346,"median":-11.154992,"eighty":-10.467461,"marketCap":7904636090},{"date":"2023-09-08","current":-3.045502,"twenty":-12.394972,"median":-11.061159,"eighty":-10.227752,"marketCap":6323708872},{"date":"2023-09-15","current":-3.276331,"twenty":-12.381613,"median":-10.935179,"eighty":-6.512762,"marketCap":6855751685},{"date":"2023-09-22","current":-3.006155,"twenty":-12.36402,"median":-10.844647,"eighty":-3.792803,"marketCap":6262903979},{"date":"2023-09-29","current":-2.913601,"twenty":-12.34839,"median":-10.788114,"eighty":-3.305013,"marketCap":6080489300},{"date":"2023-10-06","current":-3.060747,"twenty":-12.287596,"median":-10.741943,"eighty":-3.213384,"marketCap":6384513765},{"date":"2023-10-13","current":-3.036132,"twenty":-12.066426,"median":-10.551151,"eighty":-3.148051,"marketCap":6323708872},{"date":"2023-10-20","current":-3.106604,"twenty":-11.932534,"median":-10.469238,"eighty":-3.120451,"marketCap":6460519881},{"date":"2023-10-27","current":-2.925118,"twenty":-11.796455,"median":-10.343076,"eighty":-3.068613,"marketCap":6080489300},{"date":"2023-11-03","current":-2.990305,"twenty":-11.691357,"median":-10.218458,"eighty":-3.045502,"marketCap":6232501532},{"date":"2023-11-10","current":-3.268138,"twenty":-11.654904,"median":-9.796084,"eighty":-3.060747,"marketCap":6810148016},{"date":"2023-11-17","current":-3.108791,"twenty":-11.613111,"median":-4.217909,"eighty":-3.060747,"marketCap":6536525997},{"date":"2023-11-24","current":-2.853944,"twenty":-11.467369,"median":-3.800488,"eighty":-3.019641,"marketCap":6050086853},{"date":"2023-12-01","current":-2.756466,"twenty":-11.417592,"median":-3.514265,"eighty":-2.990305,"marketCap":5867672174},{"date":"2023-12-08","current":-2.351787,"twenty":-11.401481,"median":-3.313885,"eighty":-2.93822,"marketCap":4986001226},{"date":"2023-12-15","current":-1.83926,"twenty":-11.309603,"median":-3.276331,"eighty":-2.913601,"marketCap":3921915598},{"date":"2023-12-22","current":-1.398202,"twenty":-11.281516,"median":-3.266894,"eighty":-2.872719,"marketCap":2979439757},{"date":"2023-12-29","current":-1.558248,"twenty":-11.205602,"median":-3.218707,"eighty":-2.860632,"marketCap":3338188625},{"date":"2024-01-05","current":-1.057644,"twenty":-11.154992,"median":-3.21182,"eighty":-2.802771,"marketCap":2249781041},{"date":"2024-01-12","current":-0.999942,"twenty":-11.150782,"median":-3.160184,"eighty":-2.759084,"marketCap":2128171255},{"date":"2024-01-19","current":-0.956974,"twenty":-11.111144,"median":-3.130992,"eighty":-2.490877,"marketCap":2033923670},{"date":"2024-01-26","current":-1.01241,"twenty":-11.026152,"median":-3.120712,"eighty":-2.309623,"marketCap":2143372478},{"date":"2024-02-02","current":-0.936815,"twenty":-10.964346,"median":-3.106604,"eighty":-1.836456,"marketCap":1980801062},{"date":"2024-02-09","current":-0.896369,"twenty":-10.938224,"median":-3.073227,"eighty":-1.544488,"marketCap":1904616406},{"date":"2024-02-16","current":-0.959266,"twenty":-10.919956,"median":-3.067843,"eighty":-1.412953,"marketCap":2038701401},{"date":"2024-02-23","current":-0.899483,"twenty":-10.863612,"median":-3.062215,"eighty":-1.31118,"marketCap":1901569020},{"date":"2024-03-01","current":-1.152465,"twenty":-10.844647,"median":-3.040182,"eighty":-1.17923,"marketCap":2437909000},{"date":"2024-03-08","current":-0.971959,"twenty":-10.843385,"median":-3.012898,"eighty":-1.152465,"marketCap":2056985718},{"date":"2024-03-15","current":-1.145767,"twenty":-10.800615,"median":-3.003359,"eighty":-1.102403,"marketCap":2422672068},{"date":"2024-03-22","current":-1.210287,"twenty":-10.775614,"median":-2.971683,"eighty":-1.108733,"marketCap":2556757063},{"date":"2024-03-28","current":-1.130651,"twenty":-10.768565,"median":-2.94471,"eighty":-1.126268,"marketCap":2404387751},{"date":"2024-04-05","current":-1.018114,"twenty":-10.746915,"median":-2.925118,"eighty":-1.078437,"marketCap":2163644237},{"date":"2024-04-12","current":-1.011803,"twenty":-10.711537,"median":-2.916466,"eighty":-1.052694,"marketCap":2151454692},{"date":"2024-04-19","current":-0.965334,"twenty":-10.642392,"median":-2.906537,"eighty":-1.046989,"marketCap":2050890946},{"date":"2024-04-26","current":-1.03546,"twenty":-10.539635,"median":-2.868164,"eighty":-1.036496,"marketCap":2197165486},{"date":"2024-05-03","current":-1.095099,"twenty":-10.513514,"median":-2.860037,"eighty":-1.038246,"marketCap":2322108322},{"date":"2024-05-10","current":-1.015083,"twenty":-10.47457,"median":-2.807837,"eighty":-1.032578,"marketCap":2157549465},{"date":"2024-05-17","current":-1.060526,"twenty":-10.460353,"median":-2.785798,"eighty":-1.029219,"marketCap":2239828893},{"date":"2024-05-24","current":-1.149726,"twenty":-10.37667,"median":-2.759739,"eighty":-1.030854,"marketCap":2422672068},{"date":"2024-05-31","current":-1.040202,"twenty":-10.309482,"median":-2.716272,"eighty":-1.030854,"marketCap":2194118100},{"date":"2024-06-07","current":-0.954703,"twenty":-10.241692,"median":-2.483148,"eighty":-1.020882,"marketCap":2011274925},{"date":"2024-06-14","current":-0.88753,"twenty":-10.223105,"median":-2.348826,"eighty":-1.015017,"marketCap":1868047771},{"date":"2024-06-21","current":-0.879235,"twenty":-9.893357,"median":-2.097181,"eighty":-1.011704,"marketCap":1846716067},{"date":"2024-06-28","current":-0.930402,"twenty":-9.799284,"median":-1.836923,"eighty":-1.004715,"marketCap":1953374586},{"date":"2024-07-05","current":-0.911731,"twenty":-9.796084,"median":-1.670031,"eighty":-0.989934,"marketCap":1913758565},{"date":"2024-07-12","current":-0.998824,"twenty":-6.512762,"median":-1.535315,"eighty":-0.975822,"marketCap":2099649126},{"date":"2024-07-19","current":-1.078316,"twenty":-4.260297,"median":-1.440488,"eighty":-0.983109,"marketCap":2266795296},{"date":"2024-07-26","current":-1.109957,"twenty":-4.076914,"median":-1.398202,"eighty":-0.988979,"marketCap":2341976752},{"date":"2024-08-02","current":-1.019736,"twenty":-3.896516,"median":-1.341466,"eighty":-0.989934,"marketCap":2150360472},{"date":"2024-08-09","current":-1.088923,"twenty":-3.792803,"median":-1.273961,"eighty":-0.992426,"marketCap":2311561470},{"date":"2024-08-16","current":-1.21024,"twenty":-3.761985,"median":-1.221942,"eighty":-0.996911,"marketCap":2570091371},{"date":"2024-08-23","current":-1.4747,"twenty":-3.613333,"median":-1.260835,"eighty":-0.999495,"marketCap":3144940210},{"date":"2024-08-30","current":-6.768747,"twenty":-3.613333,"median":-1.282548,"eighty":-1.003043,"marketCap":3899239216},{"date":"2024-09-06","current":-6.86048,"twenty":-4.076914,"median":-1.344748,"eighty":-1.005589,"marketCap":3953986725},{"date":"2024-09-13","current":-7.629828,"twenty":-6.773268,"median":-1.399159,"eighty":-1.006459,"marketCap":4385883736},{"date":"2024-09-20","current":-7.679018,"twenty":-6.86048,"median":-1.408171,"eighty":-1.008176,"marketCap":4440631245},{"date":"2024-09-27","current":-8.467696,"twenty":-7.210357,"median":-1.4747,"eighty":-1.010386,"marketCap":4926157965},{"date":"2024-10-04","current":-8.045497,"twenty":-7.438254,"median":-1.528968,"eighty":-1.010794,"marketCap":4659279943},{"date":"2024-10-10","current":-6.916807,"twenty":-7.445917,"median":-1.535454,"eighty":-1.011308,"marketCap":3979699659},{"date":"2024-10-18","current":-6.535297,"twenty":-7.4076,"median":-1.599022,"eighty":-1.011803,"marketCap":3740585295},{"date":"2024-10-25","current":-6.87674,"twenty":-7.395,"median":-1.716627,"eighty":-1.011971,"marketCap":3935766258},{"date":"2024-11-01","current":-6.487355,"twenty":-7.390607,"median":-1.836923,"eighty":-1.01241,"marketCap":3715412316},{"date":"2024-11-08","current":-5.268552,"twenty":-7.067714,"median":-2.097181,"eighty":-1.012524,"marketCap":2994521565},{"date":"2024-11-15","current":-4.934518,"twenty":-6.939983,"median":-2.348826,"eighty":-1.014752,"marketCap":2783467441},{"date":"2024-11-22","current":-4.525008,"twenty":-6.921031,"median":-2.487824,"eighty":-1.015083,"marketCap":2551002028},{"date":"2024-11-29","current":-4.212716,"twenty":-6.916807,"median":-2.719501,"eighty":-1.015704,"marketCap":2373594213},{"date":"2024-12-06","current":-4.301808,"twenty":-6.905598,"median":-2.763011,"eighty":-1.018114,"marketCap":2418082775},{"date":"2024-12-13","current":-4.02776,"twenty":-6.88455,"median":-2.792596,"eighty":-1.019736,"marketCap":2261974665},{"date":"2024-12-20","current":-3.895979,"twenty":-6.880216,"median":-2.853944,"eighty":-1.020882,"marketCap":2175955910},{"date":"2024-12-27","current":-3.693493,"twenty":-6.879252,"median":-2.860037,"eighty":-1.021555,"marketCap":2061264237},{"date":"2025-01-03","current":-3.393321,"twenty":-6.877861,"median":-2.868164,"eighty":-1.023476,"marketCap":1895598486},{"date":"2025-01-10","current":-2.994045,"twenty":-6.870236,"median":-2.906537,"eighty":-1.026058,"marketCap":1666215140},{"date":"2025-01-17","current":-2.591221,"twenty":-6.86048,"median":-2.868164,"eighty":-1.027008,"marketCap":1443203553},{"date":"2025-01-24","current":-2.296545,"twenty":-6.833199,"median":-2.860899,"eighty":-1.028243,"marketCap":1287095443},{"date":"2025-01-28","current":-2.466671,"twenty":-6.805918,"median":-2.857066,"eighty":-1.028894,"marketCap":1389043597},{"date":"2025-02-07","current":-2.798033,"twenty":-6.785996,"median":-2.820002,"eighty":-1.030527,"marketCap":1567452866},{"date":"2025-02-14","current":-3.403301,"twenty":-6.780924,"median":-2.832166,"eighty":-1.031664,"marketCap":1901970246},{"date":"2025-02-21","current":-2.965189,"twenty":-6.771007,"median":-2.858982,"eighty":-1.034711,"marketCap":1666215140},{"date":"2025-02-28","current":-3.128579,"twenty":-6.737748,"median":-2.857066,"eighty":-1.035452,"marketCap":1752233895},{"date":"2025-03-07","current":-3.795937,"twenty":-6.685693,"median":-2.863309,"eighty":-1.035834,"marketCap":2134539472},{"date":"2025-03-14","current":-3.17157,"twenty":-6.632156,"median":-2.878989,"eighty":-1.03679,"marketCap":1784092693},{"date":"2025-03-21","current":-3.342788,"twenty":-6.586773,"median":-2.907899,"eighty":-1.03784,"marketCap":1879669087},{"date":"2025-03-28","current":-4.261325,"twenty":-6.543854,"median":-2.91933,"eighty":-1.038839,"marketCap":1978431362},{"date":"2025-04-03","current":-3.930581,"twenty":-6.51804,"median":-2.925118,"eighty":-1.039278,"marketCap":1825509131},{"date":"2025-04-11","current":-3.073189,"twenty":-6.495027,"median":-2.922242,"eighty":-1.03967,"marketCap":1414530635},{"date":"2025-04-17","current":-3.165897,"twenty":-6.47136,"median":-2.94471,"eighty":-1.039975,"marketCap":1459132952},{"date":"2025-04-25","current":-3.918674,"twenty":-6.44197,"median":-2.955046,"eighty":-1.041501,"marketCap":1809579732},{"date":"2025-05-02","current":-4.151319,"twenty":-6.420376,"median":-2.965975,"eighty":-1.046698,"marketCap":1921085525},{"date":"2025-05-09","current":-4.238599,"twenty":-6.416374,"median":-2.989735,"eighty":-1.04728,"marketCap":1975245482},{"date":"2025-05-16","current":-4.366995,"twenty":-6.405055,"median":-3.003359,"eighty":-1.048429,"marketCap":2051706597},{"date":"2025-05-23","current":-5.848115,"twenty":-6.313401,"median":-3.007935,"eighty":-1.050731,"marketCap":2755786035},{"date":"2025-05-30","current":-6.515833,"twenty":-6.416374,"median":-3.036132,"eighty":-1.051354,"marketCap":3083931656},{"date":"2025-06-06","current":-6.996095,"twenty":-6.508395,"median":-3.039313,"eighty":-1.052,"marketCap":3319686762},{"date":"2025-06-13","current":-8.228236,"twenty":-6.545559,"median":-3.060747,"eighty":-1.052348,"marketCap":3905888647},{"date":"2025-06-20","current":-6.374949,"twenty":-6.632156,"median":-3.067399,"eighty":-1.052744,"marketCap":3020214059},{"date":"2025-06-27","current":-6.3035,"twenty":-6.639184,"median":-3.073189,"eighty":-1.053079,"marketCap":2994727021},{"date":"2025-07-04","current":-5.954515,"twenty":-6.641618,"median":-3.086246,"eighty":-1.054062,"marketCap":2829061271},{"date":"2025-07-11","current":-5.819562,"twenty":-6.627625,"median":-3.114534,"eighty":-1.055579,"marketCap":2762157795},{"date":"2025-07-18","current":-6.720769,"twenty":-6.641618,"median":-3.123457,"eighty":-1.057059,"marketCap":3187401188},{"date":"2025-07-25","current":-6.141724,"twenty":-6.627625,"median":-3.129786,"eighty":-1.059373,"marketCap":2923374942},{"date":"2025-08-01","current":-5.729361,"twenty":-6.595465,"median":-3.139962,"eighty":-1.061686,"marketCap":2710245321},{"date":"2025-08-08","current":-5.735189,"twenty":-6.557071,"median":-3.15919,"eighty":-1.06292,"marketCap":2719788439},{"date":"2025-08-15","current":-6.274508,"twenty":-6.540468,"median":-3.165897,"eighty":-1.063408,"marketCap":2971090528},{"date":"2025-08-22","current":-6.442504,"twenty":-6.540468,"median":-3.175987,"eighty":-1.065225,"marketCap":3041073389},{"date":"2025-08-29","current":-7.115719,"twenty":-6.557071,"median":-3.21131,"eighty":-1.067861,"marketCap":3674100172},{"date":"2025-09-05","current":-7.091352,"twenty":-6.584214,"median":-3.213297,"eighty":-1.074535,"marketCap":3657890365},{"date":"2025-09-12","current":-6.910072,"twenty":-6.659199,"median":-3.2277,"eighty":-1.082356,"marketCap":3570797737},{"date":"2025-09-19","current":-6.382019,"twenty":-6.693078,"median":-3.259314,"eighty":-1.087373,"marketCap":3295585034},{"date":"2025-09-26","current":-5.904859,"twenty":-6.659199,"median":-3.275781,"eighty":-1.091631,"marketCap":3041274561},{"date":"2025-10-03","current":-6.01226,"twenty":-6.644052,"median":-3.290255,"eighty":-1.094101,"marketCap":3103981253},{"date":"2025-10-10","current":-5.838578,"twenty":-6.633708,"median":-3.310057,"eighty":-1.095198,"marketCap":3009921215},{"date":"2025-10-17","current":-5.559086,"twenty":-6.615916,"median":-3.325304,"eighty":-1.096113,"marketCap":2863605600},{"date":"2025-10-24","current":-5.333971,"twenty":-6.590347,"median":-3.359906,"eighty":-1.098444,"marketCap":2748643331},{"date":"2025-10-31","current":-5.083015,"twenty":-6.578081,"median":-3.393321,"eighty":-1.099475,"marketCap":2623229947},{"date":"2025-11-07","current":-4.181079,"twenty":-6.543931,"median":-3.413605,"eighty":-1.102403,"marketCap":2156413463},{"date":"2025-11-14","current":-4.822607,"twenty":-6.543065,"median":-3.495515,"eighty":-1.108733,"marketCap":2494332858},{"date":"2025-11-21","current":-4.392956,"twenty":-6.538737,"median":-3.605298,"eighty":-1.109957,"marketCap":2271051731},{"date":"2025-11-28","current":-4.594159,"twenty":-6.537428,"median":-3.670872,"eighty":-1.109957,"marketCap":2383695897},{"date":"2025-12-05","current":-4.264675,"twenty":-6.535297,"median":-3.715228,"eighty":-1.111553,"marketCap":2216546489},{"date":"2025-12-12","current":-4.110256,"twenty":-6.53384,"median":-3.762061,"eighty":-1.113705,"marketCap":2140239151},{"date":"2025-12-19","current":-3.613255,"twenty":-6.530763,"median":-3.749448,"eighty":-1.113705,"marketCap":1885881357},{"date":"2025-12-24","current":-3.608975,"twenty":-6.526072,"median":-3.693493,"eighty":-1.114207,"marketCap":1889515040},{"date":"2026-01-02","current":-3.173126,"twenty":-6.5201,"median":-3.677848,"eighty":-1.115526,"marketCap":1667860391},{"date":"2026-01-09","current":-3.585899,"twenty":-6.512114,"median":-3.657564,"eighty":-1.121582,"marketCap":1889515040},{"date":"2026-01-16","current":-3.285591,"twenty":-6.502385,"median":-3.621768,"eighty":-1.129331,"marketCap":1736900364},{"date":"2026-01-23","current":-3.268106,"twenty":-6.492637,"median":-3.611115,"eighty":-1.133662,"marketCap":1725999315},{"date":"2026-01-30","current":-3.301176,"twenty":-6.480864,"median":-3.592259,"eighty":-1.140204,"marketCap":1751435095},{"date":"2026-02-06","current":-3.620741,"twenty":-6.465168,"median":-3.583052,"eighty":-1.144251,"marketCap":1925851868},{"date":"2026-02-13","current":-3.498174,"twenty":-6.452683,"median":-3.572107,"eighty":-1.147341,"marketCap":1871346626},{"date":"2026-02-20","current":-3.469208,"twenty":-6.44914,"median":-3.529701,"eighty":-1.148914,"marketCap":1853178212},{"date":"2026-02-27","current":-3.108602,"twenty":-6.443477,"median":-3.500418,"eighty":-1.149721,"marketCap":1678761439},{"date":"2026-03-06","current":-3.188132,"twenty":-6.431634,"median":-3.482285,"eighty":-1.150014,"marketCap":1707830901},{"date":"2026-03-12","current":-3.450354,"twenty":-6.425452,"median":-3.469208,"eighty":-1.151513,"marketCap":1856811895}],"updateTime":1773417259379},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"02487\",pageSize:20,pageCount:1,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"1102715965","title":"CUTIA-B (02487) Sets 24 Mar 2026 Board Meeting to Approve FY2025 Results and Consider Final Dividend","url":"https://stock-news.laohu8.com/highlight/detail?id=1102715965","media":"Bulletin Express","labels":["conferences","SGX"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1102715965?lang=en_us&edition=fundamental","pubTime":"2026-03-12 16:45","pubTimestamp":1773305118,"startTime":"0","endTime":"0","summary":"Cutia Therapeutics (stock code: 02487) has scheduled a board meeting for 24 March 2026. Key agenda items include: • Reviewing and approving the consolidated annual results for the year ended 31...","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"conferences,SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02487"],"gpt_icon":0},{"id":"2618181074","title":"Cutia Therapeutics board to review annual results and consider final dividend","url":"https://stock-news.laohu8.com/highlight/detail?id=2618181074","media":"Reuters","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2618181074?lang=en_us&edition=fundamental","pubTime":"2026-03-12 16:32","pubTimestamp":1773304340,"startTime":"0","endTime":"0","summary":"Cutia Therapeutics’ board will meet on 24 March 2026 to consider and approve the group’s annual results for the year ended 31 December 2025.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Cutia Therapeutics published the original content used to generate this news brief via IIS, the Issuer Information Service operated by the Hong Kong Stock Exchange  , on March 12, 2026, and is solely responsible for the information contained therein.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260312:nNDL7ktgjW:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02487","BK1161"],"gpt_icon":0},{"id":"1148648027","title":"CUTIA-B (Stock Code: 02487) Announces February 2026 Monthly Return","url":"https://stock-news.laohu8.com/highlight/detail?id=1148648027","media":"Bulletin Express","labels":["SGX"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1148648027?lang=en_us&edition=fundamental","pubTime":"2026-03-05 21:03","pubTimestamp":1772715805,"startTime":"0","endTime":"0","summary":"Cutia Therapeutics disclosed a total authorized share capital of US$50,000, representing 2.50 billion shares at a par value of US$0.00002 each, showing no change from the preceding month. The total...","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02487"],"gpt_icon":0},{"id":"1175260908","title":"Cutia Therapeutics (02487) Announces January 2026 Monthly Return on Movements in Securities","url":"https://stock-news.laohu8.com/highlight/detail?id=1175260908","media":"Bulletin Express","labels":["SGX"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1175260908?lang=en_us&edition=fundamental","pubTime":"2026-02-05 21:07","pubTimestamp":1770296870,"startTime":"0","endTime":"0","summary":"Cutia Therapeutics reported that its authorized share capital remains at USD 50,000, represented by 2,500,000,000 ordinary shares with a par value of USD 0.00002 each. The total issued share count at...","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02487"],"gpt_icon":0},{"id":"1183335324","title":"CUTIA-B (02487) Shareholder Transfers HK$122 Million Worth of Shares from Citibank to Morgan Stanley Hong Kong Securities","url":"https://stock-news.laohu8.com/highlight/detail?id=1183335324","media":"Stock News","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1183335324?lang=en_us&edition=fundamental","pubTime":"2026-01-27 08:58","pubTimestamp":1769475506,"startTime":"0","endTime":"0","summary":"According to the latest data from the Hong Kong Stock Exchange, on January 26th, a shareholder of CUTIA-B (02487) transferred shares from Citibank to Morgan Stanley Hong Kong Securities. The...","market":"other","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU2357305700.SGD","BK4504","BK4559","LU0098860793.USD","LU0557290698.USD","LU0162691827.USD","LU1244550221.USD","LU1989772923.USD","LU1791807156.HKD","LU1366192091.USD","LU0106261372.USD","LU0128525689.USD","BK4207","LU1732800096.USD","LU1201861249.SGD","LU0882574139.USD","LU0158827781.USD","LU0158827948.USD","LU2456880835.USD","BK4566","BK4516","LU0130102774.USD","LU0310800965.SGD","C","LU0106831901.USD","MS","LU2111349929.HKD","LU2347655156.SGD","LU1363072403.SGD","LU1548497426.USD","161027","LU2417539215.USD","LU0234570918.USD","LU1720051017.SGD","LU0971096721.USD","LU1244550494.USD","LU2133065610.SGD","LU2023251221.USD","LU0528227936.USD","LU0795875086.SGD","LU0170899867.USD","LU2125154778.USD","LU0912757837.SGD","IE00BZ1G4Q59.USD","BK1161","LU0052756011.USD","BK4534","LU2462157665.USD","LU0795875169.SGD","LU0477156953.USD","LU0320765646.SGD","LU2360032135.SGD","LU2125154935.USD","BK4585","LU1791710582.SGD","LU0980610538.SGD","LU1074936037.SGD","BK4588","IE00BSNM7G36.USD","02487","BK4581","LU1267930227.SGD","IE00BKVL7J92.USD","LU2089284900.SGD","LU1791710400.SGD","LU0006306889.USD","LU1732799900.SGD","LU1668664300.SGD","LU0225283273.USD","LU0072461881.USD","LU0267386448.USD","LU1720051108.HKD","LU1162221912.USD","LU0648001328.SGD","LU1244550577.SGD","LU2236285917.USD","LU1989772840.SGD","LU2271345857.HKD","LU2089283258.USD","LU0314104364.USD","LU0130517989.USD","LU2028103732.USD","BK4127"],"gpt_icon":0},{"id":"1102366190","title":"After 10 Months of Delisting from Stock Connect, Liquidity Issues Emerge: Can R&D Breakthroughs Drive CUTIA-B (02487) to Halt Its Decline?","url":"https://stock-news.laohu8.com/highlight/detail?id=1102366190","media":"Stock News","labels":["merge"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1102366190?lang=en_us&edition=fundamental","pubTime":"2026-01-20 15:08","pubTimestamp":1768892898,"startTime":"0","endTime":"0","summary":"Following a cumulative 35.88% plunge in its share price throughout 2025, CUTIA-B (02487) appears to have yet to find the key to unlocking a rebound in 2026. As of January 19, the company's Hong Kong...","market":"sg","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"merge","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02487","BK1161"],"gpt_icon":0},{"id":"2604051970","title":"Cutia Therapeutics Reports Positive Phase III Results for CU-20101 Botulinum Toxin Injection in China","url":"https://stock-news.laohu8.com/highlight/detail?id=2604051970","media":"Reuters","labels":["dataReport","express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2604051970?lang=en_us&edition=fundamental","pubTime":"2026-01-19 08:02","pubTimestamp":1768780934,"startTime":"0","endTime":"0","summary":"Cutia Therapeutics has announced positive topline results from a Phase III clinical trial in China for CU-20101, its botulinum toxin type A injection developed for the improvement of moderate to severe glabellar lines. The clinical trial comprised two phases: a randomized, multi-center, double-blind, positive drug control study, and an open-label study to evaluate efficacy and safety. BOTOX served as the control and reference product. According to the company, the trial met its non-inferiority endpoint for efficacy, as assessed by both on-site investigators and participants, with additional confirmation from an independent assessment committee. All enrolled subjects completed the trial in November 2025, and database lock was completed in early January 2026. The results have already been presented by Cutia Therapeutics. The company noted there is no assurance CU-20101 will ultimately be successfully developed or marketed.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260119:nNDL8FtVpq:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport,express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02487","BK1161"],"gpt_icon":0},{"id":"2601135619","title":"Cutia Therapeutics' (HKG:2487) market cap surged HK$258m last week, private equity firms who have a lot riding on the company were rewarded","url":"https://stock-news.laohu8.com/highlight/detail?id=2601135619","media":"Simply Wall St.","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2601135619?lang=en_us&edition=fundamental","pubTime":"2026-01-08 09:24","pubTimestamp":1767835499,"startTime":"0","endTime":"0","summary":"Key Insights Significant control over Cutia Therapeutics by private equity firms implies that the general public has...","market":"us","thumbnail":"https://images.simplywall.st/asset/industry/6111000-choice1-main-header/1585186710114","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/industry/6111000-choice1-main-header/1585186710114"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/hk/pharmaceuticals-biotech/hkg-2487/cutia-therapeutics-shares/news/cutia-therapeutics-hkg2487-market-cap-surged-hk258m-last-wee","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/hk/pharmaceuticals-biotech/hkg-2487/cutia-therapeutics-shares/news/cutia-therapeutics-hkg2487-market-cap-surged-hk258m-last-wee","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["02487","BK4539","BK1161","LENZ","BK4007","BK4139"],"gpt_icon":0},{"id":"2595605517","title":"Cutia Therapeutics Files Director List with HKEX","url":"https://stock-news.laohu8.com/highlight/detail?id=2595605517","media":"Reuters","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2595605517?lang=en_us&edition=fundamental","pubTime":"2025-12-30 16:35","pubTimestamp":1767083721,"startTime":"0","endTime":"0","summary":"Cutia Therapeutics has filed an updated list of directors with the Hong Kong Stock Exchange. The Board consists of Executive Directors Ms. Zhang Lele and Mr. Huang Yuqing; Non-executive Directors Dr. Chen Lian Yong, Dr. Xie Qin, Mr. Lu Minfang, and Ms. Yang Yunxia; and Independent Non-executive Directors Mr. Chung Ming Kit, Mr. Zhang Zhisong, and Mr. Ye Xiaoxiang. Regarding committee memberships, Mr. Chung Ming Kit serves as Chairman of the Audit Committee, with Mr. Zhang Zhisong and Mr. Ye Xiaoxiang as members. Mr. Ye Xiaoxiang chairs the Remuneration Committee, with Mr. Chung Ming Kit and Dr. Chen Lian Yong as members. Dr. Chen Lian Yong is Chairman of the Nomination Committee, joined by Dr. Xie Qin, Mr. Chung Ming Kit, Mr. Zhang Zhisong, and Mr. Ye Xiaoxiang as members.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251230:nNDL1z0XbG:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02487","BK1161"],"gpt_icon":0},{"id":"1157976503","title":"CUTIA-B (02487): Lu Minfang Appointed as Non-Executive Director","url":"https://stock-news.laohu8.com/highlight/detail?id=1157976503","media":"Stock News","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1157976503?lang=en_us&edition=fundamental","pubTime":"2025-12-30 16:34","pubTimestamp":1767083666,"startTime":"0","endTime":"0","summary":"CUTIA-B (02487) announced that Dr. Huang Xiao has resigned from his position as a non-executive director of the company, effective December 30, 2025, due to his desire to focus more on other personal...","market":"nz","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1161","02487"],"gpt_icon":0},{"id":"2595805760","title":"Cutia Therapeutics Appoints Lu Minfang as Non-Executive Director","url":"https://stock-news.laohu8.com/highlight/detail?id=2595805760","media":"Reuters","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2595805760?lang=en_us&edition=fundamental","pubTime":"2025-12-30 16:31","pubTimestamp":1767083477,"startTime":"0","endTime":"0","summary":"Cutia Therapeutics announced that Dr. Huang Xiao has resigned as a non-executive director, effective 30 December 2025. Mr. Lu Minfang has been appointed as a new non-executive director, with an initial term of three years.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Cutia Therapeutics published the original content used to generate this news brief via IIS, the Issuer Information Service operated by the Hong Kong Stock Exchange  , on December 30, 2025, and is solely responsible for the information contained therein.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251230:nNDL5zsTGd:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1161","02487"],"gpt_icon":0},{"id":"1141706948","title":"Cutia Therapeutics (02487) Announces Monthly Return for November 2025, Issued Shares Increase to 364,730,877","url":"https://stock-news.laohu8.com/highlight/detail?id=1141706948","media":"Bulletin Express","labels":["SGX"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1141706948?lang=en_us&edition=fundamental","pubTime":"2025-12-04 21:03","pubTimestamp":1764853429,"startTime":"0","endTime":"0","summary":"Cutia Therapeutics, incorporated in the Cayman Islands with limited liability, released its monthly return for November 2025. The company’s authorized share capital remains unchanged at 2,500,000,000...","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02487"],"gpt_icon":0},{"id":"1196206557","title":"CUTIA-B (02487): CU-40105 (Self-Developed Topical Finasteride Spray) ANDA Accepted by China's NMPA","url":"https://stock-news.laohu8.com/highlight/detail?id=1196206557","media":"Stock News","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1196206557?lang=en_us&edition=fundamental","pubTime":"2025-11-19 06:10","pubTimestamp":1763503813,"startTime":"0","endTime":"0","summary":"CUTIA-B (02487) announced that the Abbreviated New Drug Application (ANDA) for its self-developed topical finasteride spray, CU-40105, has been accepted by China's National Medical Products...","market":"other","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02487","BK1161"],"gpt_icon":0},{"id":"2584969948","title":"Cutia Therapeutics' Topical Finasteride Spray ANDA Accepted by China NMPA","url":"https://stock-news.laohu8.com/highlight/detail?id=2584969948","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2584969948?lang=en_us&edition=fundamental","pubTime":"2025-11-19 06:03","pubTimestamp":1763503436,"startTime":"0","endTime":"0","summary":"Cutia Therapeutics has announced that its Abbreviated New Drug Application  for CU-40105, a self-developed topical finasteride spray for the treatment of androgenetic alopecia, has been accepted for review by the National Medical Products Administration  of China. The company highlights that topical finasteride offers an alternative to oral formulations by enabling direct application to the scalp, potentially reducing systemic drug exposure and improving patient acceptance. There is no assurance that CU-40105 will ultimately be successfully developed and marketed. No grant or funding involving multiple organizations was mentioned in the announcement.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Cutia Therapeutics published the origin","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251118:nNDL5G1rGv:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1161","02487"],"gpt_icon":0},{"id":"2584896991","title":"Cutia Therapeutics - Abbreviated New Drug Application for Cu-40105 Self-Developed Topical Finasteride Spray Accepted by Nmpa China","url":"https://stock-news.laohu8.com/highlight/detail?id=2584896991","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2584896991?lang=en_us&edition=fundamental","pubTime":"2025-11-19 06:02","pubTimestamp":1763503343,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251118:nFWN3WU122:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["02487","BK1161"],"gpt_icon":0},{"id":"1116996583","title":"CUTIA-B (02487) Sees Stock Price Halved in Two Months: When Will New Product Commercialization Drive a Rebound?","url":"https://stock-news.laohu8.com/highlight/detail?id=1116996583","media":"Stock News","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1116996583?lang=en_us&edition=fundamental","pubTime":"2025-11-18 17:38","pubTimestamp":1763458730,"startTime":"0","endTime":"0","summary":"After being removed from the Hong Kong Stock Connect list in March this year, CUTIA-B (02487) experienced a rollercoaster ride in its stock price. Although it plunged to a year-low of HK$3.64 within...","market":"fut","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1161","02487"],"gpt_icon":0},{"id":"2583639432","title":"When Will Cutia Therapeutics (HKG:2487) Become Profitable?","url":"https://stock-news.laohu8.com/highlight/detail?id=2583639432","media":"Simply Wall St.","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2583639432?lang=en_us&edition=fundamental","pubTime":"2025-11-15 06:51","pubTimestamp":1763160711,"startTime":"0","endTime":"0","summary":"Cutia Therapeutics ( HKG:2487 ) is possibly approaching a major achievement in its business, so we would like to shine...","market":"nz","thumbnail":"https://images.simplywall.st/asset/industry/6111000-choice1-main-header/1585186710114","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/industry/6111000-choice1-main-header/1585186710114"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/hk/pharmaceuticals-biotech/hkg-2487/cutia-therapeutics-shares/news/when-will-cutia-therapeutics-hkg2487-become-profitable","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/hk/pharmaceuticals-biotech/hkg-2487/cutia-therapeutics-shares/news/when-will-cutia-therapeutics-hkg2487-become-profitable","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["BK4007","BK4139","LENZ","02487","BK4539","BK1161"],"gpt_icon":0},{"id":"1102356277","title":"HK Stock Movement | CUTIA-B (02487) Surges Over 10% as Topical Minocycline Foam and Finasteride Spray Begin Domestic Sales","url":"https://stock-news.laohu8.com/highlight/detail?id=1102356277","media":"Stock News","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1102356277?lang=en_us&edition=fundamental","pubTime":"2025-11-14 14:38","pubTimestamp":1763102297,"startTime":"0","endTime":"0","summary":"CUTIA-B (02487) rose more than 10%, with a gain of 10.11% to HK$7.19 by the time of writing, recording a turnover of HK$5.78 million. Recently, CUTIA Group announced that the first batch of...","market":"fut","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02487","BK1161"],"gpt_icon":0},{"id":"2582812430","title":"Cutia Therapeutics' Acne Drug Data Selected for Oral Presentation at CDA Annual Meeting","url":"https://stock-news.laohu8.com/highlight/detail?id=2582812430","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2582812430?lang=en_us&edition=fundamental","pubTime":"2025-11-10 09:27","pubTimestamp":1762738027,"startTime":"0","endTime":"0","summary":"Cutia Therapeutics  said a post-hoc analysis of its Phase 3 clinical trial for CU-10201, a topical 4% minocycline foam for moderate to severe facial acne vulgaris, has been accepted for oral presentation at the 20th China Dermatologist Association Annual Meeting, according to a Monday bourse filing.The analysis found early efficacy, with significant improvement in inflammatory lesions within the first week of treatment, and further gains in the second week, the company said.","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["BK1161","BK4007","LENZ","BK4539","02487","BK4139"],"gpt_icon":0},{"id":"1163063896","title":"CUTIA-B (02487): Post-Hoc Analysis of CU-10201 (Topical 4% Minocycline Foam) Phase III Clinical Trial in China Selected for Oral Presentation at 20th CDA Annual Conference","url":"https://stock-news.laohu8.com/highlight/detail?id=1163063896","media":"Stock News","labels":["conferences"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1163063896?lang=en_us&edition=fundamental","pubTime":"2025-11-10 08:14","pubTimestamp":1762733662,"startTime":"0","endTime":"0","summary":"CUTIA-B (02487) announced that a post-hoc analysis of its Phase III clinical trial in China evaluating the early efficacy of CU-10201 (topical 4% minocycline foam) in treating moderate-to-severe...","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"conferences","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02487","III","BK1161","BK4134"],"gpt_icon":0}],"pageSize":20,"totalPage":2,"pageCount":1,"totalSize":23,"code":"91000000","status":"200"}]}}